References
- Nakase K, Tsuji K, Nagaya S, Tamaki S, Tanigawa M, Ikeda T, et al. Acute interstitial pneumonitis during chemotherapy for haematological malignancy. Eur J Cancer Care (Engl) 2005;14:336-41. https://doi.org/10.1111/j.1365-2354.2005.00589.x
- Meadors M, Floyd J, Perry MC. Pulmonary toxicity of chemotherapy. Semin Oncol 2006;33:98-105. https://doi.org/10.1053/j.seminoncol.2005.11.005
- Azoulay E, Attalah H, Yang K, Herigault S, Jouault H, Brun-Buisson C, et al. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats. Crit Care Med 2003; 31:157-65. https://doi.org/10.1097/00003246-200301000-00025
- Aggarwal A, Baker CS, Evans TW, Haslam PL. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 2000;15:895-901. https://doi.org/10.1034/j.1399-3003.2000.15e14.x
- Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, Fuchs D, Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003;23:729-36. https://doi.org/10.1089/107999003772084842
- Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986;133:321-40.
- Burger RM, Peisach J, Horwitz SB. Activated bleomycin: a transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem 1981;256: 11636-44.
- Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74: 2644-51.
- Yuan L, Inoue S, Saito Y, Nakajima O. An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry. Exp Cell Res 1993;209:375-81. https://doi.org/10.1006/excr.1993.1323
- Iijima S, Tsuji T, Sugita M, Yamada N, Satoh T, Kubo T. Leukocyte activity and occurrence of tissue injury by G-CSF. Nihon Sanka Fujinka Gakkai Zasshi 1993;45: 213-9.
- Mendoza JF, Caceres JR, Santiago E, Mora LM, Sanchez L, Corona TM, et al. Evidence that G-CSF is a fibroblast growth factor that induces granulocytes to increase phagocytosis and to present a mature morphology, and that macrophages secrete 45-kd molecules with these activities as well as with G-CSF-like activity. Exp Hematol 1990;18:903-10.
- Brieva J. Cyclophosphamide-induced acute respiratory distress syndrome. Respirology 2007;12:769-73. https://doi.org/10.1111/j.1440-1843.2007.01128.x
- Katsuya H, Suzumiya J, Sasaki H, Ishitsuka K, Shibata T, Takamatsu Y, et al. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma. Leuk Lymphoma 2009;50:1818-23. https://doi.org/10.3109/10428190903258780
- Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, et al. Increased incidence of interstitial pneumonia by CHOP combined with rituximab. Int J Hematol 2008;87:393-7. https://doi.org/10.1007/s12185-008-0066-7
- Togashi Y, Masago K, Handa T, Tanizawa K, Okuda C, Sakamori Y, et al. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer. Clin Lung Cancer 2012;13: 304-11. https://doi.org/10.1016/j.cllc.2011.11.001
Cited by
- Cyclophosphamide/lenograstim : Interstitial pneumonitis in an elderly patient: case report vol.1462, pp.1, 2013, https://doi.org/10.1007/s40278-013-4732-z